-
Optimized hiPSC Platelet Differentiation: Study Insights
2026-09-21
A 2026 study presents an optimized embryoid body–based protocol for generating functional platelets from human induced pluripotent stem cells. By increasing the starting cell input, refining the medium, replacing selected cytokines with small molecules, and improving megakaryocyte maturation, the authors shortened production to 19 days, increased platelet yield, and reduced reported costs.
-
Bergenin Targets γδT17 Cells in Psoriasis
2026-09-21
A 2026 Phytomedicine study identifies a PPARγ–PROX1 ubiquitination pathway through which bergenin suppresses pathogenic γδT17-cell activity and IL-17A production in psoriasis models. Its combination of immune-cell profiling, metabolic analysis, ubiquitination assays, and chromatin studies provides a mechanistic framework for evaluating plant-derived interventions while highlighting the limitations of translating imiquimod-based findings to patients.
-
Imeglimin and Mitochondrial Function in Carpal Tunnel
2026-09-20
The reference study evaluates whether imeglimin can improve mitochondrial performance in subsynovial connective tissue-derived cells from patients with idiopathic carpal tunnel syndrome. Its multi-endpoint design links mitochondrial bioenergetic, oxidative, structural, and cell-death phenotypes, providing a useful framework for interpreting mitochondrial dysfunction in patient-derived musculoskeletal models.
-
ALDH2 Activation Delays Pressure-Overload Heart Failure
2026-09-19
A 2025 Experimental Cell Research study identifies ALDH2 as a regulator of cardiomyocyte proliferative capacity, not only as a mitochondrial aldehyde-detoxifying enzyme. In neonatal mice and adult mice subjected to transverse aortic constriction, ALDH2 activation increased cardiomyocyte proliferation and delayed pressure overload-induced heart failure, providing a rationale for further cardiac regeneration research.
-
Esculetin, CKLF1, and Neutrophil Infiltration After Stroke
2026-09-19
This study identifies CKLF1-mediated neutrophil recruitment as a mechanistic link between post-stroke inflammation and impaired neurological recovery. In a mouse photothrombotic stroke model, esculetin reduced infarction, improved behavior and motor-cortex connectivity, and produced these effects through a pathway involving CKLF1, CCR5, and neutrophil infiltration.
-
TNF-alpha recombinant murine protein in apoptosis
2026-09-18
Use TNF-alpha recombinant murine protein as a defined receptor-mediated apoptosis stimulus and as an orthogonal comparator for transcription-inhibition experiments. Its strong L929 bioactivity, species-matched format, and controlled reconstitution workflow help distinguish cytokine signaling from the Pol II degradation-dependent apoptotic response.
-
β-Blocker Selectivity and Hematopoietic Engraftment
2026-09-17
The reference study shows that β-adrenergic receptor selectivity influences hematopoietic recovery after transplantation: carvedilol impaired regeneration, whereas the β1-selective inhibitor metoprolol did not. Concordant mouse and human findings suggest that nonselective β-blockade may be especially consequential after allogeneic transplantation with chemotherapy-based graft-versus-host disease prophylaxis.
-
ALDH2 Activation Delays Pressure-Overload Heart Failure
2026-09-17
A 2025 Experimental Cell Research study identifies ALDH2 as more than a mitochondrial aldehyde-detoxifying enzyme: its activation extended the early postnatal proliferative window of mouse cardiomyocytes and delayed pressure overload-induced heart failure in adults. The findings support ALDH2 as a research target linking redox control, cardiomyocyte cell-cycle regulation, and potential cardiac repair, while remaining limited to preclinical mouse models.
-
EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) Guide
2026-09-17
Explore how EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) supports transient Cas12a genome-editing workflows. This guide translates Cpf1 engineering evidence into practical decisions about guide design, controls, delivery, and assay interpretation.
-
High-Content Screening of Schistosome Stem Cells
2026-09-16
Perera, Chioni, and Walker developed a quantitative high-content assay that measures somatic neoblast proliferation in developmentally advanced liver-stage Schistosoma mansoni schistosomula rather than relying only on motility or gross morphology. Screening a stem cell-focused compound collection identified prioritized molecules that disrupted parasite development and stem cell proliferation, establishing a useful framework for anti-schistosomal lead discovery and target generation.
-
Cell Cycle Assay Kit: From DNA to Mechanism
2026-09-15
The Cell Cycle Assay Kit K2263 turns propidium iodide DNA-content profiles into a mechanistic readout of cell-cycle arrest and apoptosis. Learn how to interpret G0/G1, S, G2/M, and sub-G1 populations in colorectal cancer studies inspired by recent CGF research.
-
3X (DYKDDDDK) Peptide: Workflow Guide
2026-09-15
The 3X (DYKDDDDK) Peptide supports sensitive FLAG-based detection, affinity capture, and assay development without requiring a bulky fusion partner. This practical guide connects peptide competition, metal-aware immunoassays, protein crystallization with FLAG tag, and cyanobacterial interaction studies to reproducible laboratory workflows.
-
Amyloid Beta-peptide (25-35) in Neurotoxicity Assays
2026-09-14
Build a reproducible Alzheimer's disease neurotoxicity model with Aβ25-35 while separating peptide-handling effects from genuine neuronal or microglial responses. This workflow connects acute cytotoxicity, mitochondrial and ROS readouts, amyloid aggregation studies, and pathway-level validation informed by recent microglial research.
-
ALDH2 Activator Study: Cardiomyocyte Proliferation
2026-09-14
The reference study identifies ALDH2 activation as a way to extend the early proliferative window of mouse cardiomyocytes and delay pressure overload-induced heart failure. Its two-stage design links neonatal cardiomyocyte biology with an adult transverse aortic constriction model, providing a mechanistic framework for cardiac regeneration research while leaving important translational questions unresolved.
-
RIPA Lysis Buffer (Medium) for EV Signaling
2026-09-13
RIPA Lysis Buffer (Medium) provides a practical route from cell or tissue disruption to pathway-resolved protein analysis in extracellular-vesicle cancer studies. This guide shows how to use its balanced detergent system for Western blotting, immunoprecipitation, phosphoprotein analysis, and assay troubleshooting without confusing sample preparation with biological validation.